Stock 002412 HUNAN HANSEN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hunan Hansen Pharmaceutical Co., Ltd.

Equities

002412

CNE100000PK2

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-03 EDT 		5-day change 1st Jan Change
5.67 CNY -0.70% Intraday chart for Hunan Hansen Pharmaceutical Co., Ltd. -2.91% -16.37%
05-29 Hunan Hansen Pharmaceutical's Gets Nod to Make Changes to Iopamidol Injection MT
04-26 Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Hunan Hansen Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of traditional Chinese medicine preparations, chemical medicine and medical preparations. The Company’s main products include Simotang oral liquid, used for abdominal distention and phlegmatic abdominalgia; Yushangling capsules, used for injuries from falls; Yinxingye capsules, used for stroke and chest distress, as well as Suoquan capsules, used for kidney deficiency, among others. The Company mainly distributes its products in domestic markets.

Number of employees: 1,536

Sales per Business

CNY in Million2022Weight2023Weight Delta
Siliutang Oral Liquid
56.5 %
533 58.2 % 540 56.5 % +1.23%
Tianma Xingnao Capsules
16.8 %
134 14.6 % 161 16.8 % +19.99%
Shrinking Capsules
8.7 %
76 8.3 % 83 8.7 % +8.21%
Solid Oral Preparations
7.4 %
66 7.2 % 70 7.4 % +7.46%
Gingko Biloba Capsule
5.3 %
56 6.1 % 50 5.3 % -10.58%
Intestinal
3.0 %
22 2.4 % 29 3.0 % +29.75%
Yushangling Capsule
0.7 %
8 0.9 % 7 0.7 % -15.97%
Liquid Oral Formulation
0.6 %
5 0.5 % 6 0.6 % +17.02%
Gastrointestinal Capsules
0.3 %
3 0.3 % 3 0.3 % +2.86%
Injection
0.3 %
6 0.6 % 3 0.3 % -54.20%
Gallbladder Pain Capsules
0.3 %
3 0.3 % 2 0.3 % -21.41%
Other
0.2 %
4 0.4 % 2 0.2 % -44.61%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
916 100.0 % 956 100.0 % +4.31%

Managers

Managers TitleAgeSince
Zheng Qing Liu CEO
 Chief Executive Officer 60 08-01-19
Jiang Hong Dai DFI
 Director of Finance/CFO 54 20-05-24
Sai Cheng Liu CHM
 Chairman 62 20-05-24
Jian Jun Fu BRD
 Director/Board Member 60 14-05-08
Ling Song Ao BRD
 Director/Board Member 52 08-01-19
Ren Hui Fu BRD
 Director/Board Member 54 08-01-19
Xi Wen Zhang IRC
 Investor Relations Contact - -
Ai Hua Liu PRN
 Corporate Officer/Principal 53 08-01-19

Members of the board

Members of the board TitleAgeSince
Zheng Qing Liu CEO
 Chief Executive Officer 60 08-01-19
Ping Zhan BRD
 Director/Board Member 59 20-05-18
Ren Hui Fu BRD
 Director/Board Member 54 08-01-19
Ling Song Ao BRD
 Director/Board Member 52 08-01-19
Jian Jun Fu BRD
 Director/Board Member 60 14-05-08
Bing Yang Liu BRD
 Director/Board Member 33 23-05-22
Jin Song Xia BRD
 Director/Board Member 49 20-05-18
Gao Yun Hu BRD
 Director/Board Member 61 20-05-18
Sai Cheng Liu CHM
 Chairman 62 20-05-24
Chen Chen BRD
 Director/Board Member 39 23-05-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 503,200,000 235,040,998 ( 46.71 %) 0 46.71 %

Shareholders

NameEquities%Valuation
China Asset Management Co., Ltd.
0.5226 %
2,556,900 0.5226 % 2 M ¥
Gfund Management Co., Ltd.
0.3378 %
1,652,670 0.3378 % 1 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.2634 %
1,288,800 0.2634 % 1 M ¥
Wanjia Asset Management Co., Ltd.
0.2433 %
1,190,500 0.2433 % 948 590 ¥
Essence Fund Co., Ltd.
0.0933 %
456,400 0.0933 % 363 660 ¥
Zhong Ou Asset Management Co., Ltd
0.0646 %
316,200 0.0646 % 251 948 ¥
Penghua Fund Management Co., Ltd.
0.0161 %
79,000 0.0161 % 62 947 ¥
Morgan Stanley Huaxin Fund Management Co., Ltd.
0.005804 %
28,400 0.005804 % 22 629 ¥
HFT Investment Management Co., Ltd.
0.004190 %
20,500 0.004190 % 16 334 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.001410 %
6,900 0.001410 % 5 498 ¥

Company contact information

Hunan Hansen Pharmaceutical Co. Ltd.

No. 2688, Yincheng Avenue Heshan District

413000, Yiyang

+

http://www.hansenzy.com
address Hunan Hansen Pharmaceutical Co., Ltd.(002412)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
HUNAN HANSEN PHARMACEUTICAL CO., LTD. Stock Hunan Hansen Pharmaceutical Co., Ltd.
-16.37% 397M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.83% 748B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.70% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.06% 325B
ABBVIE INC. Stock AbbVie Inc.
+4.63% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 245B
NOVARTIS AG Stock Novartis AG
+9.26% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-4.21% 209B
PFIZER, INC. Stock Pfizer, Inc.
+2.43% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002412 Stock
  4. Company Hunan Hansen Pharmaceutical Co., Ltd.